BioSpace News Archive

Business

Juniper Pharmaceuticals Reports Full-Year 2017 Financial and Operating Results

Full Year CRINONE® Revenues Increased 20% and Juniper Pharma Services (JPS) Revenues Increased 32% Year-over-Year Ended 2017 Cash Flow Positive; Company Expects Trend to Continue in 2018 Conference Call at 8:30 a.m. EST Today

March 8, 2018
·
16 min read
Pharm Country

Ortho Clinical Diagnostics Launches Ortho’s VITROS® C-peptide Assay

Assay is now commercially available in the U.S. and countries accepting CE Mark

March 8, 2018
·
4 min read
Business

Cantel Medical Reports Record Financial Results for its Second Quarter Fiscal Year 2018

Cantel Medical Corporation announced financial results for its second quarter ended January 31, 2018.

March 8, 2018
·
2 min read
Biotech Bay

National Analysis Projects 2019 Premium Hikes of 30 Percent in Some States and Cumulative Increases of 90 Percent or More in the Next Three Years

A new analysis finds that every state in the nation is at risk for higher than normal premium increases due to continued policy changes and uncertainty at the federal level.

March 8, 2018
·
4 min read
Business

Genomic Health Announces 2017 Fourth Quarter and Year-end Financial Results, Provides 2018 Financial Outlook

Achieved $1.9M Profit in the Fourth Quarter; Reported Net Loss of $3.9M for the Full Year Delivered $0.4M Full-year Profit on a Non-GAAP Basis Excluding Business Development Transaction Costs Delivered 7 Percent Test Growth and 6 Percent Revenue Growth in the Fourth Quarter Guides to Double-digit Revenue Growth and Full-year Profitability in 2018

March 8, 2018
·
29 min read
BioMidwest

PierianDx Launches Clinical Genomics Services to Accelerate Precision Medicine

PierianDx, the leading genomics technology company that enables precision medicine, announced today a full range of expanded services to support adoption of the company’s enterprise software platform, the Clinical Genomics WorkSpace (CGW).

March 8, 2018
·
2 min read
Business

Tango Therapeutics Expands Board of Directors with the Addition of Leading Oncology Experts with Deep Experience in Targeted and Personalized Therapies

Tango Therapeutics, a biotechnology company creating novel, targeted medicines for specific cancer subtypes, today announced the addition of three experienced leaders with deep backgrounds in personalized cancer research, drug discovery and development to the board of directors.

March 8, 2018
·
3 min read
Genetown

New Research Demonstrates Enhanced Sensitivity for Acute HIV Detection Using Quanterix’ Simoa Technology

Quanterix Corporation announced its industry-leading single molecule array, or Simoa, technology has achieved enhanced sensitivity for the detection of acute HIV infection relative to currently approved fourth-generation antigen-antibody (Ag/Ab) combination (combo) and stand-alone p24 assays.

March 8, 2018
·
4 min read
Job Trends

Metactive Medical Raises $1.2 Million of Additional Capital and Awarded $1.5 Million Grant from the National Institutes of Health

Metactive Medical Inc. announced it has closed an additional $1.2 million in Series A financing from a group of investors, including Mid-America Angels and Serra Ventures, bringing the total funding raised to date more than $10 million.

March 8, 2018
·
2 min read
Business

Catabasis Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Financial Results and Recent Corporate Developments on Thursday, March 15

The Company will Host a Conference Call at 4:30pm ET

March 8, 2018
·
1 min read